美国国立综合癌症网络（NCCN）肿瘤学临床实践指南：前列腺癌 - Suppr

NCCN clinical practice guidelines in oncology: prostate cancer.

作者信息

Mohler James, Bahnson Robert R, Boston Barry, Busby J Erik, D'Amico Anthony, Eastham James A, Enke Charles A, George Daniel, Horwitz Eric Mark, Huben Robert P, Kantoff Philip, Kawachi Mark, Kuettel Michael, Lange Paul H, Macvicar Gary, Plimack Elizabeth R, Pow-Sang Julio M, Roach Mack, Rohren Eric, Roth Bruce J, Shrieve Dennis C, Smith Matthew R, Srinivas Sandy, Twardowski Przemyslaw, Walsh Patrick C

出版信息

J Natl Compr Canc Netw. 2010 Feb;8(2):162-200. doi: 10.6004/jnccn.2010.0012.

DOI:10.6004/jnccn.2010.0012

PMID:20141676

Abstract

摘要

相似文献

NCCN clinical practice guidelines in oncology: prostate cancer.

J Natl Compr Canc Netw. 2010 Feb;8(2):162-200. doi: 10.6004/jnccn.2010.0012.

[Conference on the treatment of prostatic cancer. Munich, Germany, 2-3 November 1996].

Prog Urol. 1997 Dec;7(6):1020-2.

EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.

Eur Urol. 2017 Apr;71(4):618-629. doi: 10.1016/j.eururo.2016.08.003. Epub 2016 Aug 25.

[Practice guideline 'Prostate cancer: diagnosis and treatment'].

Ned Tijdschr Geneeskd. 2008 Aug 9;152(32):1771-5.

What your patient needs to know about prostate cancer.

Nursing. 2002 Dec;32(12):36-42; quiz N232. doi: 10.1097/00152193-200212000-00040.

[Modern therapy of prostate cancer].

MMW Fortschr Med. 2014 Dec 15;156(21-22):71-3. doi: 10.1007/s15006-014-3815-y.

Prognosis based on postoperative PSA levels and treatment in prostate cancer with lymph node involvement.

Int J Clin Oncol. 2024 Oct;29(10):1586-1593. doi: 10.1007/s10147-024-02580-6. Epub 2024 Jul 8.

Serum prostate-specific antigen elevation in the post-radical prostatectomy patient.

Urol Clin North Am. 1996 Nov;23(4):665-75. doi: 10.1016/s0094-0143(05)70344-x.

The prostate cancer conundrum.

J Natl Cancer Inst. 2003 Jul 2;95(13):930-1. doi: 10.1093/jnci/95.13.930.

[Treatment for cancer specifically diagnosed in high-aged population, prostate cancer].

Nihon Ronen Igakkai Zasshi. 2006 Jan;43(1):71-3. doi: 10.3143/geriatrics.43.71.

引用本文的文献

Adaption of the Memorial Sloan Kettering Cancer Center Nomograms for the Prediction of Prostate Cancer-specific Death in Sweden: A Population-based Cohort Study.

Eur Urol Open Sci. 2025 Jul 14;78:41-50. doi: 10.1016/j.euros.2025.06.003. eCollection 2025 Aug.

Family History of Early Onset or Lethal Prostate Cancer and the Risk of Prostate Cancer Death in Sweden.

Cancer Epidemiol Biomarkers Prev. 2025 Sep 2;34(9):1585-1592. doi: 10.1158/1055-9965.EPI-25-0198.

Can Genomic Classifiers in Biopsy Cores With Grade Group 1 Cancer Predict Higher-Grade Disease Elsewhere in the Prostate? Results From the Prospective Miami Active Surveillance Trial.

J Urol. 2025 Jun 20:101097JU0000000000004652. doi: 10.1097/JU.0000000000004652.

MRI-detected extranodal extension as a marker of prostate cancer aggressiveness.

Eur Radiol. 2025 Apr 5. doi: 10.1007/s00330-025-11532-1.

Using real-world, population-level data to assess the uptake of active surveillance for low-grade prostate cancer before and after the release of clinical guidelines.

Can Urol Assoc J. 2025 Jun;19(6):158-164. doi: 10.5489/cuaj.9019.

A first-in-human study of JNJ-70218902, a bispecific T-cell-redirecting antibody against TMEFF2 in metastatic castration-resistant prostate cancer.

Oncologist. 2025 Jan 17;30(1). doi: 10.1093/oncolo/oyae313.

Current status and therapeutic value of extended pelvic lymph node dissection during radical prostatectomy for prostate cancer.

Prostate Int. 2024 Sep;12(3):117-127. doi: 10.1016/j.prnil.2024.03.002. Epub 2024 Mar 17.

Impact of aspirin on biochemical recurrence of prostate cancer after robot assisted radical prostatectomy in a multicenter retrospective cohort study.

Sci Rep. 2025 Jan 15;15(1):2025. doi: 10.1038/s41598-025-86521-x.

Quantitative 3-T Multiparametric MRI Parameters as Predictors of Aggressive Prostate Cancer.

Radiol Imaging Cancer. 2025 Jan;7(1):e240011. doi: 10.1148/rycan.240011.

Prognostic value of baseline alkaline phosphatase of 177Lu-PSMA radioligand therapy in metastatic castration-resistant prostate cancer: A systematic review and meta-analysis.

PLoS One. 2024 Dec 12;19(12):e0307826. doi: 10.1371/journal.pone.0307826. eCollection 2024.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

NCCN clinical practice guidelines in oncology: prostate cancer.

作者信息

出版信息

J Natl Compr Canc Netw. 2010 Feb;8(2):162-200. doi: 10.6004/jnccn.2010.0012.

DOI:10.6004/jnccn.2010.0012

PMID:20141676

Abstract

摘要

相似文献

NCCN clinical practice guidelines in oncology: prostate cancer.

J Natl Compr Canc Netw. 2010 Feb;8(2):162-200. doi: 10.6004/jnccn.2010.0012.

[Conference on the treatment of prostatic cancer. Munich, Germany, 2-3 November 1996].

Prog Urol. 1997 Dec;7(6):1020-2.

EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.

Eur Urol. 2017 Apr;71(4):618-629. doi: 10.1016/j.eururo.2016.08.003. Epub 2016 Aug 25.

[Practice guideline 'Prostate cancer: diagnosis and treatment'].

Ned Tijdschr Geneeskd. 2008 Aug 9;152(32):1771-5.

What your patient needs to know about prostate cancer.

Nursing. 2002 Dec;32(12):36-42; quiz N232. doi: 10.1097/00152193-200212000-00040.

[Modern therapy of prostate cancer].

MMW Fortschr Med. 2014 Dec 15;156(21-22):71-3. doi: 10.1007/s15006-014-3815-y.

Prognosis based on postoperative PSA levels and treatment in prostate cancer with lymph node involvement.

Int J Clin Oncol. 2024 Oct;29(10):1586-1593. doi: 10.1007/s10147-024-02580-6. Epub 2024 Jul 8.

Serum prostate-specific antigen elevation in the post-radical prostatectomy patient.

Urol Clin North Am. 1996 Nov;23(4):665-75. doi: 10.1016/s0094-0143(05)70344-x.

The prostate cancer conundrum.

J Natl Cancer Inst. 2003 Jul 2;95(13):930-1. doi: 10.1093/jnci/95.13.930.

[Treatment for cancer specifically diagnosed in high-aged population, prostate cancer].

Nihon Ronen Igakkai Zasshi. 2006 Jan;43(1):71-3. doi: 10.3143/geriatrics.43.71.

引用本文的文献

Adaption of the Memorial Sloan Kettering Cancer Center Nomograms for the Prediction of Prostate Cancer-specific Death in Sweden: A Population-based Cohort Study.

Eur Urol Open Sci. 2025 Jul 14;78:41-50. doi: 10.1016/j.euros.2025.06.003. eCollection 2025 Aug.

Family History of Early Onset or Lethal Prostate Cancer and the Risk of Prostate Cancer Death in Sweden.

Cancer Epidemiol Biomarkers Prev. 2025 Sep 2;34(9):1585-1592. doi: 10.1158/1055-9965.EPI-25-0198.

Can Genomic Classifiers in Biopsy Cores With Grade Group 1 Cancer Predict Higher-Grade Disease Elsewhere in the Prostate? Results From the Prospective Miami Active Surveillance Trial.

J Urol. 2025 Jun 20:101097JU0000000000004652. doi: 10.1097/JU.0000000000004652.

MRI-detected extranodal extension as a marker of prostate cancer aggressiveness.

Eur Radiol. 2025 Apr 5. doi: 10.1007/s00330-025-11532-1.

Using real-world, population-level data to assess the uptake of active surveillance for low-grade prostate cancer before and after the release of clinical guidelines.

Can Urol Assoc J. 2025 Jun;19(6):158-164. doi: 10.5489/cuaj.9019.

A first-in-human study of JNJ-70218902, a bispecific T-cell-redirecting antibody against TMEFF2 in metastatic castration-resistant prostate cancer.

Oncologist. 2025 Jan 17;30(1). doi: 10.1093/oncolo/oyae313.

Current status and therapeutic value of extended pelvic lymph node dissection during radical prostatectomy for prostate cancer.

Prostate Int. 2024 Sep;12(3):117-127. doi: 10.1016/j.prnil.2024.03.002. Epub 2024 Mar 17.

Impact of aspirin on biochemical recurrence of prostate cancer after robot assisted radical prostatectomy in a multicenter retrospective cohort study.

Sci Rep. 2025 Jan 15;15(1):2025. doi: 10.1038/s41598-025-86521-x.

Quantitative 3-T Multiparametric MRI Parameters as Predictors of Aggressive Prostate Cancer.

Radiol Imaging Cancer. 2025 Jan;7(1):e240011. doi: 10.1148/rycan.240011.

Prognostic value of baseline alkaline phosphatase of 177Lu-PSMA radioligand therapy in metastatic castration-resistant prostate cancer: A systematic review and meta-analysis.

PLoS One. 2024 Dec 12;19(12):e0307826. doi: 10.1371/journal.pone.0307826. eCollection 2024.

NCCN clinical practice guidelines in oncology: prostate cancer.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

NCCN clinical practice guidelines in oncology: prostate cancer.

作者信息

出版信息

相似文献

引用本文的文献